InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Ocumension Therapeutics. Officer active across 1 company, notably EyePoint Pharmaceuticals, Inc.. In total, 2 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €47.3m. Activity tracked since 5 December 2023. The latest transaction was disclosed on 11 January 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations